BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35730887)

  • 1. GASTROINTESTINAL STROMAL TUMOR: OUTCOMES OF THE PAST DECADE IN A REFERENCE INSTITUTION IN SOUTHERN BRAZIL.
    Everling EM; Marchet D; DE-Antoni NM; Isbert BBM; Alves GV; Grezzana-Filho TJM
    Arq Bras Cir Dig; 2022; 35():e1658. PubMed ID: 35730887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
    Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
    DeMatteo RP; Ballman KV; Antonescu CR; Corless C; Kolesnikova V; von Mehren M; McCarter MD; Norton J; Maki RG; Pisters PW; Demetri GD; Brennan MF; Owzar K;
    Ann Surg; 2013 Sep; 258(3):422-9. PubMed ID: 23860199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative imatinib facilitates complete resection of locally advanced primary GIST by a less invasive procedure.
    Yang W; Yu J; Gao Y; Shen Q; Zhang Q; Liu X; Zhao Z; Shi X; Zhu K; Ma Y
    Med Oncol; 2014 Sep; 31(9):133. PubMed ID: 25056206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
    Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
    Cananzi FC; Lorenzi B; Belgaumkar A; Benson C; Judson I; Mudan S
    Langenbecks Arch Surg; 2014 Mar; 399(3):323-32. PubMed ID: 24413830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
    Rutkowski P; Andrzejuk J; Bylina E; Osuch C; Switaj T; Jerzak vel Dobosz A; Grzesiakowska U; Jurkowska M; Woźniak A; Limon J; Dębiec-Rychter M; Siedlecki JA
    Med Oncol; 2013 Dec; 30(4):765. PubMed ID: 24217870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy.
    Pandey R; Kochar R
    J Gastrointest Cancer; 2012 Dec; 43(4):547-52. PubMed ID: 22847491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.
    Blesius A; Cassier PA; Bertucci F; Fayette J; Ray-Coquard I; Bui B; Adenis A; Rios M; Cupissol D; Pérol D; Blay JY; Le Cesne A
    BMC Cancer; 2011 Feb; 11():72. PubMed ID: 21324142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
    Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
    Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
    Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
    Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.
    Chang SC; Liao CH; Wang SY; Tsai CY; Chiang KC; Cheng CT; Yeh TS; Chen YY; Ma MC; Liu CT; Yeh CN
    Medicine (Baltimore); 2015 Jun; 94(24):e1014. PubMed ID: 26091448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.
    Zhao WY; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Cao H; Zhang ZG
    BMC Gastroenterol; 2014 Jun; 14():105. PubMed ID: 24906683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of adjuvant imatinib therapy in improving the prognosis of patients with colorectal gastrointestinal stromal tumours.
    Li Y; Meng X
    Ann R Coll Surg Engl; 2015 Apr; 97(3):215-20. PubMed ID: 26263807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.
    McCarter MD; Antonescu CR; Ballman KV; Maki RG; Pisters PW; Demetri GD; Blanke CD; von Mehren M; Brennan MF; McCall L; Ota DM; DeMatteo RP;
    J Am Coll Surg; 2012 Jul; 215(1):53-9; discussion 59-60. PubMed ID: 22726733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and prognosis of different treatments on 63 patients with small intestinal gastrointestinal stromal tumors].
    Liu L; Liu Y; Wu X; Chen L; Xu W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):344-7. PubMed ID: 24760642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.